Martin S. Springer

7.3k total citations
65 papers, 4.9k citations indexed

About

Martin S. Springer is a scholar working on Molecular Biology, Virology and Immunology. According to data from OpenAlex, Martin S. Springer has authored 65 papers receiving a total of 4.9k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 19 papers in Virology and 19 papers in Immunology. Recurrent topics in Martin S. Springer's work include HIV Research and Treatment (19 papers), Chemokine receptors and signaling (12 papers) and Receptor Mechanisms and Signaling (12 papers). Martin S. Springer is often cited by papers focused on HIV Research and Treatment (19 papers), Chemokine receptors and signaling (12 papers) and Receptor Mechanisms and Signaling (12 papers). Martin S. Springer collaborates with scholars based in United States, Norway and United Kingdom. Martin S. Springer's co-authors include Julius Adler, Michael F. Goy, Salvatore Siciliano, Julie A. DeMartino, Bruce L. Daugherty, Lorraine Malkowitz, Thomas E. Rollins, Anna Sirotina, Gail Van Riper and Hugh Rosen and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

Martin S. Springer

65 papers receiving 4.6k citations

Peers

Martin S. Springer

IMMUN

VIROL

ONCOL

PHYSI

Antonella Caputo Italy

Paul N. Barlow United Kingdom

Pierre A. Henkart United States

Alan S. Rosenthal United States

Alemseged Truneh United States

Bruce E. Torbett United States

Keith K. Stanley Australia

Isabelle Maridonneau‐Parini France

Matthias Geyer Germany

L A Herzenberg United States

Antonella Caputo Italy

Martin S. Springer

2.4k ×1.2

1.2k ×0.7

IMMUN

1.4k ×1.6

VIROL

605 ×0.7

ONCOL

422 ×0.6

PHYSI

Citations per year, relative to Martin S. Springer Martin S. Springer (= 1×) peers Antonella Caputo

Countries citing papers authored by Martin S. Springer

Since Specialization

Citations

This map shows the geographic impact of Martin S. Springer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin S. Springer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin S. Springer more than expected).

Fields of papers citing papers by Martin S. Springer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martin S. Springer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin S. Springer. The network helps show where Martin S. Springer may publish in the future.

Co-authorship network of co-authors of Martin S. Springer

This figure shows the co-authorship network connecting the top 25 collaborators of Martin S. Springer. A scholar is included among the top collaborators of Martin S. Springer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martin S. Springer. Martin S. Springer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Schröder, Carsten, Richard N. Pierson, Bao-Ngoc Nguyen, et al.. (2007). CCR5 Blockade Modulates Inflammation and Alloimmunity in Primates. The Journal of Immunology. 179(4). 2289–2299. 48 indexed citations

Veazey, Ronald S., Per Johan Klasse, Susan M. Schader, et al.. (2005). Protection of macaques from vaginal SHIV challenge by vaginally delivered inhibitors of virus–cell fusion. Nature. 438(7064). 99–102. 255 indexed citations

Shah, Shrenik K., Natalie Chen, Sander G. Mills, et al.. (2005). Synthesis and evaluation of CCR5 antagonists containing modified 4-piperidinyl-2-phenyl-1-(phenylsulfonylamino)-butane. Bioorganic & Medicinal Chemistry Letters. 15(4). 977–982. 22 indexed citations

Shankaran, K., Shrenik K. Shah, Malcolm MacCoss, et al.. (2004). Syntheses and SAR studies of 4-(heteroarylpiperdin-1-yl-methyl)-pyrrolidin-1-yl-acetic acid antagonists of the human CCR5 chemokine receptor. Bioorganic & Medicinal Chemistry Letters. 14(13). 3419–3424. 14 indexed citations

Wolinsky, Steven M., Ronald S. Veazey, Kevin Kunstman, et al.. (2004). Effect of a CCR5 inhibitor on viral loads in macaques dual-infected with R5 and X4 primate immunodeficiency viruses. Virology. 328(1). 19–29. 47 indexed citations

Shen, Dong‐Ming, Min Shu, Sander G. Mills, et al.. (2004). Antagonists of human CCR5 receptor containing 4-(pyrazolyl)piperidine side chains. Part 1: Discovery and SAR study of 4-pyrazolylpiperidine side chains. Bioorganic & Medicinal Chemistry Letters. 14(4). 935–939. 22 indexed citations

Springer, Martin S., et al.. (2003). Down-regulation of cell surface CXCR6 expression during T cell activation is predominantly mediated by calcineurin. Cellular Immunology. 223(1). 1–12. 18 indexed citations

Daugherty, Bruce L., Salvatore Siciliano, & Martin S. Springer. (2003). Radiolabeled Chemokine Binding Assays. Humana Press eBooks. 138. 129–134. 9 indexed citations

Hale, Jeffrey J., Richard J. Budhu, Sander G. Mills, et al.. (2002). 1,3,4-Trisubstituted pyrrolidine CCR5 receptor antagonists. Part 3: polar functionality and its effect on anti-HIV-1 activity. Bioorganic & Medicinal Chemistry Letters. 12(20). 2997–3000. 10 indexed citations

10.

Finke, Paul E., Laura C. Meurer, Bryan Oates, et al.. (2001). Antagonists of the human CCR5 receptor as anti-HIV-1 agents. Part 3: A proposed pharmacophore model for 1-[N-(methyl)-N-(phenylsulfonyl)amino]-2-(phenyl)-4-[4-(substituted)piperidin-1-yl]butanes. Bioorganic & Medicinal Chemistry Letters. 11(18). 2469–2473. 31 indexed citations

11.

Finke, Paul E., Bryan Oates, Sander G. Mills, et al.. (2001). Antagonists of the human CCR5 receptor as anti-HIV-1 agents. Part 4: synthesis and structure–Activity relationships for 1-[N-(Methyl)-N-(phenylsulfonyl)amino]-2-(phenyl)-4-(4-(N-(alkyl)-N-(benzyloxycarbonyl)amino)piperidin-1-yl)butanes. Bioorganic & Medicinal Chemistry Letters. 11(18). 2475–2479. 62 indexed citations

12.

Willoughby, Christopher A., Scott C. Berk, Kevin T. Chapman, et al.. (2001). Combinatorial synthesis of CCR5 antagonists. Bioorganic & Medicinal Chemistry Letters. 11(24). 3137–3141. 28 indexed citations

13.

Cascieri, Margaret A. & Martin S. Springer. (2000). The chemokine/chemokine-receptor family: potential and progress for therapeutic intervention. Current Opinion in Chemical Biology. 4(4). 420–427. 76 indexed citations

14.

Siciliano, Salvatore, Shawn E. Kuhmann, Navid Madani, et al.. (1999). A Critical Site in the Core of the CCR5 Chemokine Receptor Required for Binding and Infectivity of Human Immunodeficiency Virus Type 1. Journal of Biological Chemistry. 274(4). 1905–1913. 67 indexed citations

15.

Kwon, Douglas S., Morris S. Jones, Craig B. Davis, et al.. (1998). The Amino Terminus of Human CCR5 Is Required for Its Function as a Receptor for Diverse Human and Simian Immunodeficiency Virus Envelope Glycoproteins. Virology. 248(2). 357–371. 59 indexed citations

16.

Daugherty, Bruce L. & Martin S. Springer. (1997). The β-Chemokine Receptor Genes CCR1 (CMKBR1), CCR2 (CMKBR2), and CCR3 (CMKBR3) Cluster within 285 kb on Human Chromosome 3p21. Genomics. 41(2). 294–295. 27 indexed citations

17.

Daugherty, Bruce L., Salvatore Siciliano, Julie A. DeMartino, et al.. (1996). Cloning, expression, and characterization of the human eosinophil eotaxin receptor.. The Journal of Experimental Medicine. 183(5). 2349–2354. 469 indexed citations

18.

Lanza, Thomas J., Philippe L. Durette, Thomas E. Rollins, et al.. (1992). Substituted 4,6-diaminoquinolines as inhibitors of C5a receptor binding. Journal of Medicinal Chemistry. 35(2). 252–258. 72 indexed citations

19.

Hensens, Otto D., Robert P. Borris, Lawrence R. Koupal, et al.. (1991). L-156,602, a C5a antagonist with a novel cyclic hexadepsipeptide structure from Streptomyces sp. MA6348. Fermentation, isolation and structure determination.. The Journal of Antibiotics. 44(2). 249–254. 42 indexed citations

20.

Siciliano, Salvatore, Thomas E. Rollins, & Martin S. Springer. (1990). Interaction between the C5a receptor and Gi in both the membrane-bound and detergent-solubilized states.. Journal of Biological Chemistry. 265(32). 19568–19574. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact